发明授权
- 专利标题： Antiviral drugs
-
申请号： US15774390申请日： 2016-11-07
-
公开(公告)号： US10709727B2公开(公告)日： 2020-07-14
- 发明人: Shin-ichi Hashimoto , Shuichi Kaneko , Masao Honda , Takayoshi Shirasaki , Taro Yamashita
- 申请人： IDAC THERANOSTICS, INC.
- 申请人地址： JP Tokyo
- 专利权人： IDAC THERANOSTICS, INC.
- 当前专利权人： IDAC THERANOSTICS, INC.
- 当前专利权人地址： JP Tokyo
- 代理机构： Birch, Stewart, Kolasch & Birch, LLP
- 优先权： com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@47e6fde9
- 国际申请： PCT/JP2016/082957 WO 20161107
- 国际公布： WO2017/082202 WO 20170518
- 主分类号： A61K31/7105
- IPC分类号： A61K31/7105 ; A61K31/713 ; C12N15/113 ; A61K31/7088 ; A61K48/00 ; A61K31/4178 ; A61K31/4525 ; C12Q1/6883 ; C12Q1/70 ; A61K45/06 ; C12Q1/6886 ; G01N33/569 ; A61P31/20
摘要：
The present invention relates to an antiviral drug comprising as an active ingredient a substance capable of suppressing an expression of a target gene or an activity of a protein encoded by said target gene, wherein said target gene is one or more genes having an action of retaining virus-derived nucleic acid in a host cell and selected from the group consisting of DOCK11 gene, LIPG gene, DENND2A gene, and HECW2 gene. The present invention also relates to a screening method for the antiviral drug.
公开/授权文献
- US20190022126A1 ANTIVIRAL DRUGS 公开/授权日：2019-01-24
信息查询
IPC分类:
